Resistin promotes BC proliferation and metastasis by upregulating the expression of BCL-2 and BCL-XL and activating STAT3 and Toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathways [79]. The gene discussed is TLR4; the disease is breast cancer.